These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2177401)

  • 1. Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
    Barnett G; Segura J; de la Torre R; Carbó M
    Eur J Clin Pharmacol; 1990; 39(1):63-9. PubMed ID: 2177401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-quinolones inhibit biotransformation of caffeine.
    Harder S; Staib AH; Beer C; Papenburg A; Stille W; Shah PM
    Eur J Clin Pharmacol; 1988; 35(6):651-6. PubMed ID: 2853056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations.
    Harder S; Fuhr U; Staib AH; Wolff T
    Am J Med; 1989 Nov; 87(5A):89S-91S. PubMed ID: 2589393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of quinolones on caffeine disposition.
    Carbó M; Segura J; De la Torre R; Badenas JM; Camí J
    Clin Pharmacol Ther; 1989 Mar; 45(3):234-40. PubMed ID: 2920498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine.
    Mahr G; Sörgel F; Granneman GR; Kinzig M; Muth P; Patterson K; Fuhr U; Nickel P; Stephan U
    Clin Pharmacokinet; 1992; 22 Suppl 1():90-7. PubMed ID: 1319876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans.
    Sano M; Kawakatsu K; Ohkita C; Yamamoto I; Takeyama M; Yamashina H; Goto M
    Eur J Clin Pharmacol; 1988; 35(2):161-5. PubMed ID: 3191935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
    Schmid DA; Depta JP; Pichler WJ
    Clin Exp Allergy; 2006 Jan; 36(1):59-69. PubMed ID: 16393267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New synthetic quinolone antibacterial agents and serum concentration of theophylline.
    Niki Y; Soejima R; Kawane H; Sumi M; Umeki S
    Chest; 1987 Oct; 92(4):663-9. PubMed ID: 3477409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-drug interactions with ciprofloxacin and other fluoroquinolones.
    Polk RE
    Am J Med; 1989 Nov; 87(5A):76S-81S. PubMed ID: 2686430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of caffeine elimination in man during co-administration of 4-quinolones.
    Stille W; Harder S; Mieke S; Beer C; Shah PM; Frech K; Staib AH
    J Antimicrob Chemother; 1987 Nov; 20(5):729-34. PubMed ID: 3480885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of quinolones on xanthine pharmacokinetics.
    Robson RA
    Am J Med; 1992 Apr; 92(4A):22S-25S. PubMed ID: 1580270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effect of fluoroquinolones on theophylline metabolism in human liver microsomes.
    Sarkar M; Polk RE; Guzelian PS; Hunt C; Karnes HT
    Antimicrob Agents Chemother; 1990 Apr; 34(4):594-9. PubMed ID: 2344166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between quinolones and caffeine.
    Staib AH; Stille W; Dietlein G; Shah PM; Harder S; Mieke S; Beer C
    Drugs; 1987; 34 Suppl 1():170-4. PubMed ID: 3481318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bactericidal effect on Pseudomonas strains of adriamycin associated with quinolones.
    Castelli M; Baggio G; Aresca P; Bossa R; Galatulas I
    Anticancer Res; 1989; 9(3):611-4. PubMed ID: 2504105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.
    Fuhr U; Anders EM; Mahr G; Sörgel F; Staib AH
    Antimicrob Agents Chemother; 1992 May; 36(5):942-8. PubMed ID: 1510417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of drug metabolism by quinolone antibiotics.
    Edwards DJ; Bowles SK; Svensson CK; Rybak MJ
    Clin Pharmacokinet; 1988 Sep; 15(3):194-204. PubMed ID: 3052987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gyrase inhibitors modify metabolising processes in the liver].
    Staib AH; Harder S; Papenburg A; Stille W
    Dtsch Med Wochenschr; 1987 Oct; 112(44):1720-1. PubMed ID: 2822371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.